Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Girentuximab |
| Trade Name | Rencarex |
| Synonyms | WX-G250|chimeric monoclonal antibody cG250 |
| Drug Descriptions |
Rencarex (Girentuximab) is a monoclonal antibody that targets G250, an antigen expressed by renal cell carcinoma cells, with potential utility as a carrier for other therapeutic agents (PMID: 30487460). |
| DrugClasses | |
| CAS Registry Number | 916138-87-9 |
| NCIT ID | C1960 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Girentuximab | Girentuximab | 0 | 1 |